Potential role for BCG in treatment of autoimmune diseasesBMJ 2016; 355 doi: http://dx.doi.org/10.1136/bmj.i6091 (Published 21 November 2016) Cite this as: BMJ 2016;355:i6091
- Nigel Curtis, professor of paediatric infectious diseases
- The University of Melbourne and Murdoch Children’s Research Institute, Royal Children’s Hospital Melbourne, Parkville, Victoria 3052, Australia
The WHO Strategic Advisory Group of Experts (SAGE) reviews present the evidence from epidemiological1 and immunological2 studies in humans that suggest beneficial heterologous (non-specific) effects of BCG vaccination. Adding to this evidence, but not included …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial